Last reviewed 2026-04-20 · How we verify

K-CAB

Wonkwang University Hospital · FDA-approved active Small molecule Quality 6/100

At a glance

Generic name	K-CAB
Sponsor	Wonkwang University Hospital
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

FENOX Trial (Comparative Effectiveness of Fexuprazan Co-therapy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants) (NA)
A Study to Evaluate the Pharmacokinetics and Food-effect of IN-M00002 Tablet in Healthy Adult Volunteers (PHASE1)
Effect of Tegoprazan for Elective Surgery Patients Under General Anesthesia (PHASE4)
A Study of JNJ-70033093 (Milvexian) in Healthy Adult Participants (PHASE1)
Serratus Anterior Plan Block (SAP) and Pectoralis (PECSI-II) Blocks on Left Internal Mammarian Artery (LIMA) Blood Flow (NA)
Prevention of Dysrhythmias on the Cardiac Intensive Care Unit - Does Maintenance of High-normal Serum Potassium Levels Matter (PHASE3)
PK, PD and Safety of Tegoprazan 12.5 mg After Oral Administration in Healthy Subjects (PHASE1)
Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Subjects (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results